nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

26. Diabetes mellitus und Schwangerschaft

verfasst von : Ute M. Schaefer-Graf, Alexandra Kautzky-Willer

Erschienen in: Die Geburtshilfe

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Betreuung einer Schwangeren mit Typ-1- oder Typ-2-Diabetes stellt eine große Herausforderung dar. Durch eine präkonzeptionelle Optimierung der Blutzuckereinstellung und Behandlung von Spätkomplikationen können schwere mütterliche (Progression von Retino- und Nephropathie, Stoffwechselentgleisung in Richtung hyper- oder hypoglykämisches Koma, eine erhöhte Inzidenz von Präeklampsie, Infektionen) wie kindliche Komplikationen (Hyperinsulinismus, der mit Makrosomie, Organomegalie, intrauterinerer Asphyxie; Frühgeburtlichkeit, intrauterine Wachstumsrestriktion/Fruchttod) verringert werden.

Die Probleme beim Gestationsdiabetes (GDM) entsprechen teilweise (diabetische Fetopathie) denen von Schwangerschaften mit vorbestehendem Diabetes mellitus. Sie sind allerdings wegen fehlender diabetischer Spätkomplikationen und geringerer Hyperglykämie weniger ausgeprägt und nicht mit einer diabetischen Embryopathie assoziiert.

Vorheriges Kapitel Infektionen in der Schwangerschaft und bei der Geburt

Nächstes Kapitel Alloimmunerkrankungen und Schwangerschaft

Adlersberg MA, Burrow GN (2002) Focus on primary care. Thyroid function and dysfunction in women. Obstet Gynecol Surv 57(Suppl 3):S1–S7CrossRefPubMed

Aerts L, Holemans K, Van Assche F (1990) Maternal diabetes during pregnancy: consequences for the offspring. Diabetes Metab Rev 6:147–167CrossRefPubMed

American College of Obstetrians and Gynecologists – ACOG (2005) Pregestational diabetes mellitus, Pract Bull 60. Obstet Gynecol 105:675–684CrossRef

American Diabetes Association (2003) Gestational diabetes. Diabetes Care 26(Suppl 1):S103–S105

American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 32:S62–S67. doi:10.2337/dc09-S062CrossRef

AWMF-Leitlinien-Register (2011) Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes Nr 057/008 www.awmf-leitlinien.de

AWMF-Leitlinien-Register (2003) Leitlinie zur Betreuung Neugeborener diabetischer Mütter. Nr 024/006 www.awmf-leitlinien.de

Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J (2012) Periconception hyperglycemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 55:936–947CrossRef

Bernstein IM, Catalano PM (1992) Influence of fetal fat on the ultrasound estimation of fetal weight in diabetic mothers. Obstet Gynecol 79:561–563PubMed

Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, Fournier A, Gillet JY, Gin H, Grandperret-Vauthier S, Geudj AM, Guionnet B, Hauguel-de-Mouzon S, Hieronimus S, Hoffet M, Jullien D, Lamotte MF, Lejeune V, Lepercq J, Lorenzi F, Mares P, Miton A, Penfornis A, Pfister B, Renard E, Rodier M, Roth P, Sery GA, Timsit J, Valat AS, Vambergue A, Verier-Mine O, Diabetes and Pregnancy Group, France (2003) French multicentric survey of outcomes of pregnancy in women with pregestational diabetes. Diabetes Care 26:2990–2993CrossRefPubMed

Bung P, Artal R, Khodiguian N, Kjos S (1991) Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 40(Suppl 2):182–185CrossRefPubMed

Cederberg J, Siman M, Eriksson U (2001) Combined treatment with vitamin C and vitamin E decrease oxidative stress and improves fetal outcome in experimental diabetic pregnancies. Pediatr Res 49:755–762CrossRefPubMed

Chauhan S, Perry K, McLaughlin B, Roberts W, Sullivan C, Morrison J (1996) Diabetic ketoazidosis complicating pregnancy. J Perinatol 16:173–175PubMed

Chew E, Mill J, Metzger B, Remaley L, Jovanovic L, Knopp R (1995) Metabolic control and progression of retinopathy: the diabetes in early pregnancy study. Diabetes Care 18:631–637CrossRefPubMed

Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P (2006) Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28:323–328CrossRef

Coomarasamy A, Papaioannou S, Gee H, Khan K (2001) Asperin for the prevention opf preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. Obstet Gynecol 98:861–866PubMed

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon P, Hall K, Ray W (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451CrossRefPubMed

Cousins L (1995) Obstetrical complications. In: Reece E, Coustan D (Hrsg) Diabetes mellitus in pregnancy, Bd 2. Churchill Livingstone, New York

Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA (1989) Maternal age and screening for gestational diabetes. A population based study. Obstet Gynecol 73:557–561PubMed

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcome. N Engl J Med 352:2477–2486CrossRefPubMed

Cundy T, Gamble G, Townend K (2000) Type II diabetes mellitus in pregnancy was associated with greater perinatal mortality than type 1 diabetes in pregnancy or gestational diabetes. Diabet Med 17:33–39CrossRefPubMed

Eriksson U, Wentzel P, Hod M (2003) Clinical and experimental advances in the understanding of diabetic embryopathy. In: Hod M, Jovanovic L, Di Renzo G, De Leiva A, Langer O (Hrsg) Textbook of diabetes and pregnancy. Dunitz, London

Evers I, de Valk H, Visser G (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 10:1136–1141

Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E (1983) Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 6:219–223CrossRefPubMed

Goldberg RJ, Ye C, Sermer M, Connelly PW, Hanley AJ, Zinman B, Retnakaran R (2012) Circadian variation in the response to the glucose challenge test in pregnancy: implications for screening for gestational diabetes mellitus. Diabetes Care 35(7):1578–1584CrossRefPubMedPubMedCentral

Hod M, Jovanovic L, Di Renzo G, De Leiva A, Langer O (2003) Textbook of diabetes and pregnancy, Bd 1. Dunitz, London

Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H (2008) Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 198(2):186.e1–186.e7CrossRef

Hummel M (2004) Bekommt mein Kind auch Diabetes? In: Kleinwechter H, Schäfer-Graf U, Mäder U (Hrsg) Der große Schwangerschaftsratgeber für Diabetikerinnen. Thieme-Trias, Stuttgart

International Association of Diabetes and Pregnancy Study Groups (2010) Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRef

Jensen DM, Korsholm L, OvesenP B-NH, Moelstat-Pedersen L, Westergaard J, Moeller M, Damm P (2009) Peri-conceptual HbA_1c and risk for serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32:1046–1048CrossRefPubMedPubMedCentral

Kainer F, Weiss PAM, Hüttner U, Haas J (1997) Ultrasound growth parameters in relation to levels of amniotic fluid insulin in women with diabetes type I. Early Hum Dev 49:113–121CrossRefPubMed

Kautzky-Willer A, Prager R, Thomaseth K, Pacini G, Streli C, Waldhäusl W, Wagner O, Ludvik B (1997) Pronounced insulin resistance and inadequate beta-cell insulin secretion characterize lean gestational diabetes mellitus. Diabetes Care 20:1717–1723CrossRefPubMed

Kautzky-Willer A, Prager R, Ludvik B, Pacini G, Tura A, Bieglmeyer C, Schneider B, Waldhäusl W (2001) Elevated plasma leptin in gestational diabetes. Diabetologia 44:164–172CrossRefPubMed

Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, Prikoszovich T, Steiner H, Shnawa N, Schernthaner G, Birnbacher R, Schneider B, Marth C, Roden M, Lechleitner M (2008) The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in Central European Women. J Clin Endocrinol Metab 93:1689–1695CrossRefPubMed

Kerner W, Fuchs C, Redaelli M et al (2001) Definition, Klassifikation und Diagnosik des Diabetes mellitus. In: Diabetesgesellschaft (Hrsg) Evidenzbasierte Diabetesleitlinien DifferenzialdiagnoseG

Kimmerle R, Zass R, Cupisti S et al (1995) Pregnancies in women with diabetic nephropathy: long-term for mother and child. Diabetologia 38:227–235CrossRefPubMed

Kirwan J, Mouzon H-D, Lepercq J et al (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213CrossRefPubMed

Kitzmiller J, Gavin L, Gin G, Jovanonvic-Peterson L, Main E, Zigrang W (1991) Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265:731–736CrossRefPubMed

Kitzmiller J, Dang-Kilduff D, Taslimi M (2007) Gestational diabetes after delivery. Diabetes Care 30:S225–S234CrossRefPubMed

Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL (1995) Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 173:1532–1539CrossRefPubMed

Kjos SL, Petrs RK, Xiang A, Thomas D, Schäfer U, Buchanan TA (1998) Contraception and the risk of type 2 diabetes mellitus in Latina women with prior Gestational Diabetes Mellitus. JAMA 280:533–538CrossRefPubMed

Kjos S, Schäfer-Graf U, Sardesi S et al (2001) A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24:1904–1910CrossRefPubMed

Kjos S, Berkowitz K, Kung B (2002) Prospective delivery of reliably dated term infants of diabetic mothers without determination of fetal lung maturity: comparison to historical control. J Matern Fetal Neonatal Med 12:433–437CrossRefPubMed

Knowler W, Barett-Connor E, Fowler S et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed

Kremer C, Duff P (2004) Glyburide for treatment of gestational diabetes. Am J Obstet Gynecol 190:1438–1439CrossRefPubMed

Lambert K, Holt RIG (2013) The use of insulin analogues in pregnancy. Diabetes Obes Metab 15(120):888–900CrossRefPubMed

Landon MB, Spong CY, Thom E, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361(14):1396–1398CrossRef

Langer O, Conway D, Berkus M (2000) A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134–1138CrossRefPubMed

Langer O, Yogev Y, Most O, Xenakis E (2005) Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 192:989–997CrossRefPubMed

Larciprete G, Valensise H, Vasapollo B et al (2003) Fetal subcutaneous tissue thickness in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol 22:591–597CrossRefPubMed

Lepercq J, Lin J, Hall GC et al (2012) Meta-analysis of maternal and neonatal outcomes associataed with the use of insulin glargine versus nph insulin during pregnancy. Obstet Gynecol Int 649070. doi:10.1155/2012/649070

Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golightly S, Miller A (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. Br Med J 333(7560):177CrossRef

Martinez-Frias M (1994) Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51:108–113CrossRefPubMed

Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A (2007) Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 30(4):771–776CrossRefPubMed

Mathiesen ER, Damm P, Jovanovic L, Mc Cance D, Thyregod C, Jensen AB, Hod M (2011) Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev 27:543–551CrossRefPubMed

Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, Damm P, McCance DR, on behalf of the Detemir in Pregnancy Study Group (2012) Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 35:2012–2017CrossRefPubMedPubMedCentral

Mayhew T, Sörensen F, Klebe J, Jackson M (1994) Growth and maturation of villi in placentae from well controlled diabetic women. Placenta 15:57–65CrossRefPubMed

Metzger BE, Lowe LP, Dyer AR, Trimble ER, Sheridan B, Hod M, Chen R, Yogev Y, Coustan DR, Catalano PM, Giles W, Lowe J, Hadden DR, Persson B, Oats JJ, HAPO Study Cooperative Research Group (2008a) Hyperglycemia and adverse pregnancy outcome (HAPO) Study. Associations with neonatal Anthropometrics. Diabetes. db08–1

Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA, HAPO Study Cooperative Research Group (2008b) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002CrossRefPubMed

Metzger BE, Dyer AR (2014) New threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk? Diabetes Care 37(2)

Murphy H, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell P, Temple R (2008) Effectiveness of continous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br Med J 337:a1680. doi:10.1136/bmj.a1680CrossRef

Nielsen LR, Damm P, Mathiesen ER (2009) Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 32(1):38–44, Epub 2008 Oct 22CrossRefPubMedPubMedCentral

Plagemann A, Harder T, Rake A et al (1999) Malformation of hypothalamic nuclei in hyperinsulinaemic offspring of gestational diabetic mother rats. Int J Dev Neurosci 17:37–44CrossRefPubMed

Pollex E et al (2011) Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother 45:9–16CrossRefPubMed

Purdy L, Hantsch C, Molitch M, Metzger B, Phelps R, Dooley S (1996) Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 19:1067–1074CrossRefPubMed

Reece E, Homko C, Hagay Z (1996) Diabetic retinopathy. Obstet Gynecol Clin North Am 23:161–171CrossRefPubMed

Reiher H, Somville T (1998) Betreuung der schwangeren Diabetikerin aus geburtshilflicher Sicht. Gynakologe 31:38–46CrossRef

Reiher H, Fuhrmann K, Noack S et al (1983) Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 6:446–451CrossRefPubMed

Ringholm L, Secher AL, Pedersen-Bjergaard U, Thorsteinsson B, Andersen HU, Damm P, Mathiesen ER The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA_1c levels and pregnancy outcomes in a routine care setting. Diabetes Res Clin Pract pii: S0168–8227(13)00228-3. doi:10.1016/j.diabres.2013.06.002

Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER (2012) Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med 29:558–566CrossRefPubMed

Rosenn B, Miodovnik M, Holcberg G, Khoury J, Siddiqi T (1995) Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 85:417–422CrossRefPubMed

Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, Investigators MGT (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358:2003–2015CrossRefPubMed

Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM (2011) Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34(10):2279–2284CrossRefPubMedPubMedCentral

Ryan E (2001) What is gestational diabetes? In: Gerstein H, Hynes R (Hrsg) Evidence-based diabetes-care. BC Decker, Ontario

Ryan E (2003) Hormones and insulin resistance during pregnancy. Lancet 362:1777–1778CrossRefPubMed

Sacks D, Chen W (2000) Estimating fetal weight in the management of macrosmia. Obstet Gynecol Surv 55:229–332CrossRefPubMed

Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, Lowe LP, Coustan DR, Hod M, Oats JJ, Persson B, Trimble ER, HAPO Study Cooperative Research Group (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35(3):526–528CrossRefPubMedPubMedCentral

Sadauskaitė-Kuehne V, Ludvigsson J, Padaiga Ž, Jašinskienė E, Samuelsson U (2004) Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. Diabetes Metab Res Rev 20:150–157CrossRefPubMed

Sanchez-Ramos L, Bernstein S, Kaunitz A (2002) Expectant Management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol 100:997–1002CrossRefPubMed

Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL (1997) Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 177:1165–1171CrossRefPubMed

Schaefer-Graf U, Buchanan T, Xiang A, Songster G, Montoro M, Kjos S (2000) Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313–320CrossRefPubMed

Schaefer-Graf U, Kjos S, Bühling K et al (2003) Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med 20:349–354CrossRefPubMed

Schaefer-Graf U, Kjos S, Fauzan O et al (2004) A randomized trial evaluating a predominately fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27:297–302CrossRefPubMed

Schaefer-Graf U, Pawliczek J, Passow D et al (2005) Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 28:1745–1750CrossRefPubMed

Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, Herrera E (2008) Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31(9):1858–1863CrossRefPubMedPubMedCentral

Schaefer-Graf UM, Klavehn S, Hartmann R, Kleinwechter H, Demandt N, Sorger M, Kjos SL, Vetter K, Abou-Dakn M (2009) How do we reduce the number of missed postpartum diabetes in women with recent gestational diabetes? Diabetes Care 32(11):1960–1964CrossRefPubMedPubMedCentral

Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, Cohen HR, McArthur K, Holzapfel S, Biringer A et al (1994) Impact of time since last meal on the gestational glucose challenge test. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 171(3):607–616CrossRefPubMed

Silverman B, Rizzo T, Cho N, Metzger B (1998) Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 21(Suppl 2):142–149

Stene L, Magnus P, Lie R, Sovik O, Joner G (2001) Birth weight and childhood onset type 1 diabetes: population based cohort study. Br Med J 322:889–892CrossRef

Stoz F, Schuhmann RA, Schultz R (1988) Morphohistometric investigations of placentas of diabetic patients in correlation to the metabolic adjustment of the disease. J Perinat Med 16:211–216CrossRefPubMed

Towner D, Kjos SL, Leung B et al (1995) Congenital malformations in pregnancies complicated by NIDifferenzialdiagnoseM. Diabetes Care 18:1446–1451CrossRefPubMed

Vogel M (1967) Plakopathia diabetica. Entwicklungsstörungen der Plazenta bei Diabetes mellitus der Mutter. Virchows Arch Pathol Anat 346:212–223CrossRef

Weiss PAM (1988) Gestational diabetes: a survey and the Graz approach to diagnosis and therapy. In: Weiss P, Coustan D (Hrsg) Gestational diabetes. Springer, WienCrossRef

Wood S, Jick H, Sauve R (2003) The risk of stillbirth in pregnancies before and after the onset of diabetes. Diabet Med 20:703–707CrossRefPubMed

Xiang AH, Kawakubo M, Kjos SL, Buchanan TA (2006) Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29(3):613–617CrossRefPubMed

Ziegler A, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721–1728CrossRefPubMed

Titel: Diabetes mellitus und Schwangerschaft
verfasst von: Ute M. Schaefer-Graf
Alexandra Kautzky-Willer
Verlag: Springer Berlin Heidelberg
Buch: Die Geburtshilfe
Print ISBN: 978-3-662-45063-5

Electronic ISBN: 978-3-662-45064-2

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/978-3-662-45064-2_26

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten